Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioScrip Inc (NASDAQ:BIOS)

2.65
Delayed Data
As of Aug 26
 -0.10 / -3.64%
Today’s Change
1.19
Today|||52-Week Range
3.09
+51.43%
Year-to-Date
BioScrip (BIOS) Posts Strong Q2, Strategic Plans on Track
Aug 16 / Zacks.com - Paid Partner Content
Company News for August 15, 2016
Aug 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close2.75
Today’s open2.74
Day’s range2.61 - 2.78
Volume477,858
Average volume (3 months)822,476
Market cap$301.8M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-101.79%
Earnings growth (this year)+45.12%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)-0.19%
P/E ratioNM
Price/Sales0.12
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DITAMCON Distributing C...+2.25+2.53%
CBAYCymaBay Therapeutics...-0.01-0.43%
ACETAceto Corp-5.53-21.53%
AGXArgan Inc-0.14-0.29%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$982.2M
Annual profit (last year)-$288.3M
Net profit margin-30.89%

Profile

Sector
Health Services
Industry
Managed Health Care
President, Chief Executive Officer &
Director
Richard M. Smith
Chief Operating Officer &
Senior Vice President
James Chris Luthin
Corporate headquarters
Denver, Colorado

Forecasts

Partner Offers

Search for Jobs